Anti-IMMP2L antibodies are used in the immunodetection of the protein inner mitochondrial membrane peptidase subunit 2. In humans, the canonical protein has a reported length of 175 amino acid residues and a mass of 19.7 kDa. Its subcellular localization is in the mitochondria. Up to 2 different isoforms have been reported for this protein. It is reported to be expressed in all tissues tested except adult liver and lung. A member of the Peptidase S26 protein family, IMMP2L is known to catalyze the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. The IMMP2L gene has been associated with the disease, Gilles de la Tourette syndrome. Synonyms for this target antigen include IMP2 inner mitochondrial membrane peptidase-like, IMP2 inner mitochondrial membrane protease-like, inner mitochondrial membrane peptidase 2 like, and mitochondrial inner membrane protease subunit 2. Some IMMP2L antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.